VETmAb Biosciences, Inc.

VETmAb Biosciences, Inc.

生物技术研究

San Diego,CA 287 位关注者

Developing life-changing therapeutics for pets

关于我们

VETmAb BIO is a veterinary biopharmaceutical company focused on developing monoclonal antibodies ("mAbs") to treat debilitating diseases in dogs and cats. While monoclonal antibodies have provided revolutionary treatments in humans, mAbs technology has been underdeveloped in veterinary medicine. At VETmAb BIO, we’re taking advantage of human-validated targets and designing them specifically for dogs and cats, thereby mitigating technical risk. By utilizing our proprietary technologies, we can explore potential treatments to address various unmet needs in veterinary medicine. Our team is comprised of experts who have decades of collective experience in mAb technology and animal health. Learn more: https://www.vetmab.bio/about/

网站
https://www.vetmab.bio
所属行业
生物技术研究
规模
2-10 人
总部
San Diego,CA
类型
私人持股
创立
2022
领域
Animal Health、Monoclonal Antibodies、Veterinary Medicine和Biotechnology

地点

VETmAb Biosciences, Inc.员工

动态

相似主页